financetom
Personal Finance
financetom
/
Personal Finance
/
Coronavirus in India: Here’s how insurance can be claimed for confirmed COVID-19
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Coronavirus in India: Here’s how insurance can be claimed for confirmed COVID-19
Mar 16, 2020 7:29 AM

The coronavirus outbreak has created panic among people about their insurance coverage. But don't fret. According to experts, the existing insurance policies generally cover all such cases unless specifically excluded. In order to file a claim for coronavirus infection, a policy holder needs to follow the same process that they follow during regular hospitalisation.

Live TV

Loading...

Here's all you need to understand about your insurance policy's coverage in case of coronavirus:

Health insurance policies cover all kinds of respiratory disease, which means they cover coronavirus, provided the affected person does not have COVID-19 at the time of the purchasing the policy, say experts. One can choose to go with cashless claim facility or reimbursement facility depending upon the policy terms.

Also read: Here's how coronavirus impacts your financial health

"For cashless claim, a policyholder may choose to get admitted in a network hospital and take the necessary treatment by informing the third party administrator (TPA) within the hospital," said Amit Chhabra, head - health insurance, Policybazaar. In cashless claim, the policyholder does not pay any incurred expenses for the treatment of illness.

"While in reimbursement process, the policyholder may take treatment at any choice of hospital after informing the insurer and pay the incurred bills. All these bills are later reimbursed to the policyholder up to the sum insured after proper verification from the insurer," Chhabra explained. In any form of insurance, there are terms and conditions, exclusions, or waiting periods as per which claims are settled or rejected.

Also read: Coronavirus rattles market: If you are considering investing, you need to know this

For life insurance, assuming all terms and conditions are fulfilled, death benefit claims are entertained by insurance providers. "As long as the policy holder has disclosed all details correctly at the policy purchase stage, the death benefit claim is payable even if it arises out of coronavirus," said Adhil Shetty, CEO, BankBazaar.

In case of life policies with add-on benefits such as critical illness or terminal illness riders, the policyholder will have to satisfy the terms and conditions of the add-on to receive its benefits.

Another important thing to know is the adequate sum-insured. While there is yet to be a consensus on the treatment cost, Chhabra said that estimated sum insured of Rs 10 lakh per person is recommended.

First Published:Mar 16, 2020 3:29 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Hold Opinion On Share Of First Industrial Realty Trust, Inc.
Research Alert: CFRA Keeps Hold Opinion On Share Of First Industrial Realty Trust, Inc.
Oct 16, 2025
01:50 PM EDT, 10/16/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our target price by $7 to $59, applying a forward P/FFO of 18.5x our 2026 FFO estimate, in line with similarly sized industrial REIT peers. We increased our...
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Papa John's
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Papa John's
Oct 16, 2025
02:05 PM EDT, 10/16/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target price by $6 to $59, 20x our 2026 EPS estimate, a discount to its 24x three-year forward average P/E, reflecting risks from PZZA's ongoing turnaround....
Research Alert: CFRA Keeps Buy Opinion On Adss Of Taiwan Semiconductor Manufacturing Company
Research Alert: CFRA Keeps Buy Opinion On Adss Of Taiwan Semiconductor Manufacturing Company
Oct 16, 2025
11:30 AM EDT, 10/16/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target price to USD360 from USD295, reflecting 2026 P/E of 28.7x. The 25% premium to our valuation of TMSC's mother share of 23.0x is justified by...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Prologis, Inc.
Research Alert: CFRA Maintains Buy Opinion On Shares Of Prologis, Inc.
Oct 16, 2025
11:50 AM EDT, 10/16/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our 12-month target price by $13 to $138, based on 22.3x our 2026 forward P/FFO multiple, leaving our 2026 FFO estimate unchanged at $6.18 and increasing our 2025...
Copyright 2023-2026 - www.financetom.com All Rights Reserved